Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
NVLT > SEC Filings for NVLT > Form 8-K on 20-Jun-2012All Recent SEC Filings

Show all filings for NOVELOS THERAPEUTICS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for NOVELOS THERAPEUTICS, INC.

20-Jun-2012

Regulation FD Disclosure, Financial Statements and Exhibits


ITEM 7.01 REGULATION FD DISCLOSURE

A copy of the press release issued by us on June 19, 2012 announcing initial imaging results in a clinical trial of I-124-CLR1404 (LIGHT), a cancer-targeted PET imaging agent, in patients with primary or metastatic brain cancer, is furnished as Exhibit 99.1 and is incorporated by reference.



ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits 

     Number        Title

      99.1         Press Release dated June 19, 2012 entitled "Novelos
                   Therapeutics Announces Positive Initial Imaging Results in
                   Brain Cancer Trial with I-124-CLR1404(LIGHT) Cancer-Targeted
                   Pet Imaging Agent at UW Carbone Cancer Center"

  Add NVLT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for NVLT - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.